A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia
- 30 November 2006
- journal article
- Published by Elsevier BV in Experimental Hematology
- Vol. 34 (11), 1480-1489
- https://doi.org/10.1016/j.exphem.2006.06.019
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutationsBlood, 2005
- Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic CellsMolecular and Cellular Biology, 2004
- The many faces of c-MYCArchives of Biochemistry and Biophysics, 2003
- The roles of FLT3 in hematopoiesis and leukemiaBlood, 2002
- Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYCScience, 2002
- Reversible Tumorigenesis by MYC in Hematopoietic LineagesMolecular Cell, 1999
- c-Myc Target Genes Involved in Cell Growth, Apoptosis, and MetabolismMolecular and Cellular Biology, 1999
- Dominant negative MYC blocks transformation by ABL oncogenesCell, 1992
- The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.The Journal of Experimental Medicine, 1988
- Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies.Molecular and Cellular Biology, 1984